Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000322336) titled 'Text message support versus group program for pain self-management in people with ongoing pain after early breast cancer (TEMPO-P study)' on March 13.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel Type of endpoint: Efficacy

Primary Sponsor: Northern Sydney Local Health District (NSLHD)

Condition: Chronic pain Early-stage breast cancer (survivorship phase) Chronic pain Early-stage breast cancer (survivorship phase) Cancer - Breast Anaesthesiology - Pain management

Intervention: mHealth text messag...